Research uncovers additional treatment option in prostate cancer
Why I . . . practise yoga
29 March 2021Mass shootings are rare, but firearm suicides are common and kill more Americans every year
29 March 2021Research uncovers additional treatment option in prostate cancer
The standard treatment for advanced metastatic prostate cancer (PCa) is androgen deprivation therapy (ADT). And even if this is efficient in the short term, 1/3 of PCa will become resistant to ADT and develop castration-resistant prostate cancer. A new study, by Karolinska Institutet and others, shows that estrogen receptor β (ERβ) agonists together with ADT could be considered useful in the treatment.
